Cargando…

Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia

BACKGROUND: Asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections are well documented. Healthcare workers (HCW) are at increased risk of infection due to occupational exposure to infected patients. We aim to determine the prevalence of SARS-CoV-2 antibodies among HCW w...

Descripción completa

Detalles Bibliográficos
Autores principales: Woon, Yuan Liang, Lee, Yee Leng, Chong, Yoong Min, Ayub, Nor Aliya, Krishnabahawan, Swarna Lata, Lau, June Fei Wen, Subramaniam-Kalianan, Ramani, Sam, I-Ching, Chan, Yoke Fun, Sevalingam, Raj Kumar, Ramli, Azura, Chuah, Chuan Huan, Mat-Hussin, Hani, Leong, Chee Loon, Chidambaram, Suresh Kumar, Peariasamy, Kalaiarasu M., Goh, Pik Pin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982055/
https://www.ncbi.nlm.nih.gov/pubmed/33778796
http://dx.doi.org/10.1016/j.lanwpc.2021.100123
_version_ 1783667640919654400
author Woon, Yuan Liang
Lee, Yee Leng
Chong, Yoong Min
Ayub, Nor Aliya
Krishnabahawan, Swarna Lata
Lau, June Fei Wen
Subramaniam-Kalianan, Ramani
Sam, I-Ching
Chan, Yoke Fun
Sevalingam, Raj Kumar
Ramli, Azura
Chuah, Chuan Huan
Mat-Hussin, Hani
Leong, Chee Loon
Chidambaram, Suresh Kumar
Peariasamy, Kalaiarasu M.
Goh, Pik Pin
author_facet Woon, Yuan Liang
Lee, Yee Leng
Chong, Yoong Min
Ayub, Nor Aliya
Krishnabahawan, Swarna Lata
Lau, June Fei Wen
Subramaniam-Kalianan, Ramani
Sam, I-Ching
Chan, Yoke Fun
Sevalingam, Raj Kumar
Ramli, Azura
Chuah, Chuan Huan
Mat-Hussin, Hani
Leong, Chee Loon
Chidambaram, Suresh Kumar
Peariasamy, Kalaiarasu M.
Goh, Pik Pin
author_sort Woon, Yuan Liang
collection PubMed
description BACKGROUND: Asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections are well documented. Healthcare workers (HCW) are at increased risk of infection due to occupational exposure to infected patients. We aim to determine the prevalence of SARS-CoV-2 antibodies among HCW who did not come to medical attention. METHODS: We prospectively recruited 400 HCW from the National Public Health Laboratory and two COVID-19 designated public hospitals in Klang Valley, Malaysia between 13/4/2020 and 12/5/2020. Quota sampling was used to ensure representativeness of HCW involved in direct and indirect patient care. All participants answered a self-administered questionnaire and blood samples were taken to test for SARS-CoV-2 antibodies by surrogate virus neutralization test. FINDINGS: The study population comprised 154 (38.5%) nurses, 103 (25.8%) medical doctors, 47 (11.8%) laboratory technologists and others (23.9%). A majority (68.9%) reported exposure to SARS-CoV-2 in the past month within their respective workplaces. Adherence to personal protection equipment (PPE) guidelines and hand hygiene were good, ranging from 91-100% compliance. None (95% CI: 0, 0.0095) of the participants had SARS-CoV-2 antibodies detected, despite 182 (45.5%) reporting some symptoms one month prior to study recruitment. One hundred and fifteen (29%) of participants claimed to have had contact with known COVID-19 persons outside of their workplace. INTERPRETATION: Zero seroprevalence among HCW suggests a low incidence of undiagnosed COVID-19 infection in our healthcare setting during the first local wave of SARS-CoV-2 infection. The occupational risk of SARS-CoV-2 transmission within healthcare facilities can be prevented by adherence to infection control measures and appropriate use of PPE. FUNDING: Own institutional budget and the Fundamental Research Grant Scheme.
format Online
Article
Text
id pubmed-7982055
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-79820552021-03-23 Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia Woon, Yuan Liang Lee, Yee Leng Chong, Yoong Min Ayub, Nor Aliya Krishnabahawan, Swarna Lata Lau, June Fei Wen Subramaniam-Kalianan, Ramani Sam, I-Ching Chan, Yoke Fun Sevalingam, Raj Kumar Ramli, Azura Chuah, Chuan Huan Mat-Hussin, Hani Leong, Chee Loon Chidambaram, Suresh Kumar Peariasamy, Kalaiarasu M. Goh, Pik Pin Lancet Reg Health West Pac Research Paper BACKGROUND: Asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections are well documented. Healthcare workers (HCW) are at increased risk of infection due to occupational exposure to infected patients. We aim to determine the prevalence of SARS-CoV-2 antibodies among HCW who did not come to medical attention. METHODS: We prospectively recruited 400 HCW from the National Public Health Laboratory and two COVID-19 designated public hospitals in Klang Valley, Malaysia between 13/4/2020 and 12/5/2020. Quota sampling was used to ensure representativeness of HCW involved in direct and indirect patient care. All participants answered a self-administered questionnaire and blood samples were taken to test for SARS-CoV-2 antibodies by surrogate virus neutralization test. FINDINGS: The study population comprised 154 (38.5%) nurses, 103 (25.8%) medical doctors, 47 (11.8%) laboratory technologists and others (23.9%). A majority (68.9%) reported exposure to SARS-CoV-2 in the past month within their respective workplaces. Adherence to personal protection equipment (PPE) guidelines and hand hygiene were good, ranging from 91-100% compliance. None (95% CI: 0, 0.0095) of the participants had SARS-CoV-2 antibodies detected, despite 182 (45.5%) reporting some symptoms one month prior to study recruitment. One hundred and fifteen (29%) of participants claimed to have had contact with known COVID-19 persons outside of their workplace. INTERPRETATION: Zero seroprevalence among HCW suggests a low incidence of undiagnosed COVID-19 infection in our healthcare setting during the first local wave of SARS-CoV-2 infection. The occupational risk of SARS-CoV-2 transmission within healthcare facilities can be prevented by adherence to infection control measures and appropriate use of PPE. FUNDING: Own institutional budget and the Fundamental Research Grant Scheme. Elsevier 2021-03-21 /pmc/articles/PMC7982055/ /pubmed/33778796 http://dx.doi.org/10.1016/j.lanwpc.2021.100123 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Woon, Yuan Liang
Lee, Yee Leng
Chong, Yoong Min
Ayub, Nor Aliya
Krishnabahawan, Swarna Lata
Lau, June Fei Wen
Subramaniam-Kalianan, Ramani
Sam, I-Ching
Chan, Yoke Fun
Sevalingam, Raj Kumar
Ramli, Azura
Chuah, Chuan Huan
Mat-Hussin, Hani
Leong, Chee Loon
Chidambaram, Suresh Kumar
Peariasamy, Kalaiarasu M.
Goh, Pik Pin
Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia
title Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia
title_full Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia
title_fullStr Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia
title_full_unstemmed Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia
title_short Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia
title_sort serology surveillance of sars-cov-2 antibodies among healthcare workers in covid-19 designated facilities in malaysia
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982055/
https://www.ncbi.nlm.nih.gov/pubmed/33778796
http://dx.doi.org/10.1016/j.lanwpc.2021.100123
work_keys_str_mv AT woonyuanliang serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia
AT leeyeeleng serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia
AT chongyoongmin serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia
AT ayubnoraliya serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia
AT krishnabahawanswarnalata serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia
AT laujunefeiwen serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia
AT subramaniamkaliananramani serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia
AT samiching serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia
AT chanyokefun serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia
AT sevalingamrajkumar serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia
AT ramliazura serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia
AT chuahchuanhuan serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia
AT mathussinhani serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia
AT leongcheeloon serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia
AT chidambaramsureshkumar serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia
AT peariasamykalaiarasum serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia
AT gohpikpin serologysurveillanceofsarscov2antibodiesamonghealthcareworkersincovid19designatedfacilitiesinmalaysia